There are 169 papers on TyG-BMI in aging research: 2 trials and 161 observational studies in people, 6 reviews.
169 papers study it95 more mention it99 findings
31 new papers in 30 daysSee all 264 papers on TyG-BMI
At a glance
Human observational studies link higher TyG-BMI with frailty, cardiometabolic multimorbidity, and cardiovascular disease; sarcopenia and osteoporosis associations point both ways. Mortality associations also differ: higher TyG-BMI is linked with higher mortality in people at CKM stages 0–3, but lower mortality in postmenopausal women with young-onset type 2 diabetes.
99 findings in 82 papers from 2021 to 2026, 36 of them since April 2026
“as well as with every 100 unit increase in TyG-BMI (HR: 1.70, 95% CI: 1.63–1.76, P < 0.001, E value = 2.79)”
- Human trial2
- Humans161
Effects
6Depressive symptoms
downin humans1
1 study
Depressive symptoms
downin humans1
TyG-BMI is linked with lower depressive symptoms in humans (coefficient: -0.147; 95% CI: -0.292, -0.002).
“In contrast, TyG-BMI (-0.147; -0.292, -0.002) and TyG-WC (-0.163; -0.306, -0.021) exhibited a negative relationship with depressive symptoms.”
Humansn = 5,822
Frontiers in psychiatry
Cognitive function
upin humans1
1 study
Cognitive function
upin humans1
TyG-BMI is linked with better cognitive function in humans (coefficient: 0.206; 95% CI: 0.069, 0.343).
“The TyG-BMI (coefficient: 0.206; 95% confidence interval [CI]: 0.069, 0.343), TyG-WC (0.268; 0.135, 0.402), and TyG-WHtR (0.150; 0.013, 0.286) were positively associated with cognitive status.”
Humansn = 5,822
Frontiers in psychiatry
Hypertension
no changein humans1
1 study
Hypertension
no changein humans1
TyG-BMI was not clearly linked with hypertension in patients with type 2 diabetes and prediabetes.
“whereas TyG-BMI did not.”
Humansin patients with type 2 diabetes and prediabetes
Journal of medical biochemistry
Cerebral microbleeds
no changein humans1
1 study
Cerebral microbleeds
no changein humans1
TyG-BMI was not clearly linked with cerebral microbleeds in humans.
“The TyG-BMI was not significantly associated with enlarged perivascular spaces, lacunes, or cerebral microbleeds.”
Humansbrainn = 1,268
Journal of the American Heart Association
Poor self-rated mental health
no changein humans1
1 study
Poor self-rated mental health
no changein humans1
TyG-BMI was not clearly linked with poor self-rated mental health in humans (TyG-BMI above threshold 204.3).
“Above the threshold, no significant association was observed.”
HumansTyG-BMI above threshold 204.3n = 2,951
Frontiers in public health
Mortality
mediatesin humans1
1 study
Mortality
mediatesin humans1
TyG-BMI is linked with mortality in humans (hypertension) (33.1% of the relationship).
“TyG-BMI, TyG-WC, and TyG-WHtR indices accounted for 33.1%, 34.3%, and 19.1% of the relationship between CDAI and mortality, respectively.”
Humanshypertensionn = 5,276
Frontiers in nutrition
Upstream
1LCN2
mediatesin humans1
1 study
LCN2
mediatesin humans1
LCN2 is linked with TyG-BMI in humans (exploratory mediation analysis of neutrophil-associated cardiometabolic risk) (25.8%).
“Exploratory mediation analysis yielded an estimated mediated proportion of 25.8% ( P < 0.001).”
Humansexploratory mediation analysis of neutrophil-associated cardiometabolic riskn = 502
Scientific reports
Associations
56Mortality
upin humans4downin humans2no changein humans1mixedin humans1HR 0.65–1.99
8 studies
Mortality
upin humans4downin humans2no changein humans1mixedin humans1HR 0.65–1.99
TyG-BMI is associated with mortality in humans (CKM stages 0–3; fully adjusted analysis) (HR 1.99, 95% CI 1.21–3.28).
“After full adjustment, all seven indices were independently associated with ACM; TyG-BMI showed the strongest association (HR = 1.99, 95% CI: 1.21–3.28)”
HumansCKM stages 0–3; fully adjusted analysisMedian follow-up of 10.25 yearsn = 12,947
Cardiovascular diabetology
TyG-BMI is associated with mortality in humans after PSM, Q4 versus Q1 (HR 0.94, P = 0.44).
“while the Q4-versus-Q1 association remained null after PSM (HR = 0.94, P = 0.44)”
Humansafter PSM, Q4 versus Q1
Experimental gerontology
TyG-BMI is linked with a lower risk of mortality in humans (postmenopausal female patients with young-onset type 2 diabetes (YM group)) (HR 0.980, 95% CI 0.965-0.997, P = 0.018; -2% per 1 SD increase).
“triglyceride-glucose-body mass index (TyG-BMI) was an independent protective factor for the YM group (HR = 0.980, 95% CI = 0.965-0.997) (P = 0.018).”
Humanspostmenopausal female patients with young-onset type 2 diabetes (YM group)10-year follow-upfemalesn = 387
Frontiers in endocrinology
TyG-BMI is associated with mortality in humans (HSV-positive) (HR 1.22, 95% CI 1.11–1.33).
“TyG-BMI (HR: 1.22, 95% CI: 1.11-1.33)”
HumansHSV-positiveMedian follow-up of 143 monthsn = 8,465
TyG Index and Obesity-Related Measures in Relation to All-Cause Mortality Among HSV-Positive Adults
International journal of endocrinology
TyG-BMI is associated with mortality in humans (diabetes mellitus) (p-overall<0.0001, p-nonlinear<0.05).
“A U-shaped relationship was found between METS-IR, TyG-BMI, eGDR, and all-cause mortality (p-overall<0.0001, p-nonlinear<0.05).”
Humansdiabetes mellitus
ADA Scientific Sessions 2025 abstract
TyG-BMI is associated with mortality in humans (elderly diabetes patients) (p-overall < 0.0001, p-nonlinear < 0.05).
“A U-shaped relationship exists between METS-IR, TyG-BMI, eGDR, and all-cause mortality (p-overall < 0.0001, p-nonlinear < 0.05).”
Humanselderly diabetes patientsn = 1,248
Diabetology & metabolic syndrome
TyG-BMI is associated with mortality in humans (diabetes mellitus) (HR = 0.65, 95% CI 0.43-0.96).
“the 3rd quartile demonstrated a significant association with all-cause mortality (model 2: HR = 0.64, 95% CI 0.46-0.89, P = 0.009; model 3: HR = 0.65, 95% CI 0.43-0.96, P = 0.030)”
Humansdiabetes mellitusmedian follow-up of 77.3 monthsn = 1,363
BMC geriatrics
TyG-BMI is associated with mortality in advanced stages (e.g., end-stage renal disease, stage 4 CKM).
“Conversely, in advanced stages (e.g., end-stage renal disease, stage 4 CKM), the association frequently becomes U-shaped, with low TyG-BMI paradoxically linked to excess mortality.”
Reviewin advanced stages (e.g., end-stage renal disease, stage 4 CKM)
Frontiers in endocrinology
Cardiovascular disease
upin humans6+17%OR 3.988
6 studies
Cardiovascular disease
upin humans6+17%OR 3.988
TyG-BMI is associated with cardiovascular disease in humans (Highest change class of TyG-BMI; initially CVD-free participants) (OR 3.988, 95% CI 3.419–4.650).
“The highest change classes of all indices showed significantly increased CVD risk, with the strongest associations observed for TyG-BMI (OR: 3.988, 95% CI: 3.419-4.650)”
HumansHighest change class of TyG-BMI; initially CVD-free participantsMedian follow-up of 66 monthsn = 19,315
Frontiers in endocrinology
TyG-BMI is linked with a higher risk of cardiovascular disease in humans (elevated TyG-BMI and hs-CRP levels) (aHR 1.215 (95% CI 1.085-1.362)).
“presence of elevated TyG-BMI and hs-CRP levels was significantly associated with an increased risk of CVD, with an adjusted hazard ratio (aHR) of 1.215 (95% CI 1.085-1.362).”
Humanselevated TyG-BMI and hs-CRP levelsn = 9,190
Clinical nutrition ESPEN
TyG-BMI is linked with a higher risk of cardiovascular disease in humans (HR 3.58 (95% CI 2.50-5.14)).
“TyG-BMI was positively associated with CVD risk (HR = 3.58, 95% CI 2.50-5.14)”
Humans
BMC endocrine disorders
TyG-BMI is linked with a higher risk of cardiovascular disease in humans (Q4 vs Q1) (HR 1.74, 95% CI 1.51-2.01).
“TyG-BMI, TyG-waist-to-height ratio (WHtR), and TyG-weight-adjusted-waist index (WWI) were 1.36 (95%CI: 1.19-1.57), 1.74 (95%CI: 1.51-2.01)”
HumansQ4 vs Q19-year follow-upn = 6,158
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
TyG-BMI is linked with a higher risk of cardiovascular disease in humans (without diabetes, highest vs lowest tertile) (HR 1.92, 95% CI 1.19-3.10).
“TyG-body mass index (BMI) (HR 1.92, 95% CI 1.19-3.10)”
Humanswithout diabetes, highest vs lowest tertilen = 6,890
Journal of clinical lipidology
TyG-BMI raises the risk of cardiovascular disease in humans (continuous analysis (per 1-SD increase)) (+17%).
“per 1-SD increase, cardiovascular disease (CVD) risk increased by 17%, 20%, and 19% for TyG-BMI, TyG-WC, and TyG-WHtR, respectively (28 studies)”
Reviewcontinuous analysis (per 1-SD increase)n = 28
Cardiovascular diabetology
Sarcopenia
upin humans5downin humans1OR 0.14–3.34
5 studies
Sarcopenia
upin humans5downin humans1OR 0.14–3.34
TyG-BMI predicts sarcopenia in humans (cross-sectional analysis in CHARLS, compared with other candidate composite biomarkers) (AUC 0.938).
“Among the evaluated composite biomarkers, TyG-BMI showed the highest discriminative ability for sarcopenia (AUC = 0.938).”
Humanscross-sectional analysis in CHARLS, compared with other candidate composite biomarkersn = 1,343
Frontiers in cardiovascular medicine
TyG-BMI predicts sarcopenia in humans.
“Additionally, TyG-BMI yielded the largest AUC among the seven indices.”
Humansn = 5,329
Correlation Between Various Insulin Resistance Indices and Sarcopenia: Evidence from CHARLS
Research SquarePreprint
TyG-BMI is linked with a lower risk of sarcopenia in humans (OR 0.14, 95% CI 0.10–0.19).
“In fully adjusted models (Model 3), all seven IR surrogates were significantly associated with SA. Per standard-deviation increase, adjusted odds ratios (OR, 95% CI) were: TG/HDL 0.84 (0.74–0.95), TyG 0.65 (0.53–0.80), TyG-BMI 0.14 (0.10–0.19)”
Humansn = 5,329
Correlation Between Various Insulin Resistance Indices and Sarcopenia: Evidence from CHARLS
Research SquarePreprint
TyG-BMI is linked with a higher risk of sarcopenia in humans (OR 1.15, 95% CI 1.13-1.18).
“TyG-BMI: OR (95% CI): 1.15 (1.13, 1.18)”
Humansn = 4,804
Frontiers in endocrinology
TyG-BMI predicts sarcopenia in humans (AUC 0.892 (95% CI: 0.860-0.924)).
“Specifically, TyG-BMI showing the highest AUC of 0.892 (95% confidence interval: 0.860-0.924), indicating its strong predictive potential.”
Humansn = 792
Frontiers in physiology
TyG-BMI is linked with a higher risk of sarcopenia in humans (Q4 vs Q1) (OR 3.34, 95% CI: 1.92-5.80).
“followed by TyG-BMI (Q4: 3.34; 95% CI: 1.92-5.80, P < 0.001)”
HumansQ4 vs Q1n = 7,161
Scientific reports
Cardiometabolic multimorbidity
upin humans4HR 1.28–3.4
4 studies
Cardiometabolic multimorbidity
upin humans4HR 1.28–3.4
TyG-BMI is associated with cardiometabolic multimorbidity in humans (per 1-SD increase in baseline TyG-BMI) (HR 1.28, 95% CI 1.17–1.40).
“Baseline and cumulative average TyG-BMI were associated with CMM (HR per 1-SD increase 1.28, 95% CI 1.17–1.40; and 1.25, 95% CI 1.14–1.37, respectively)”
Humansper 1-SD increase in baseline TyG-BMI2015–2020n = 4,597
Scientific reports
TyG-BMI is linked with a higher risk of cardiometabolic multimorbidity in humans (elevated versus reduced eGDR-BMI, in adults with hypertension and sarcopenia) (HR > 1.5).
“Kaplan–Meier analysis demonstrated that elevated TyG–BMI conferred a stronger association with cumulative CMM incidence than reduced eGDR–BMI (HR > 1.5, p < 0.01).”
Humanselevated versus reduced eGDR-BMI, in adults with hypertension and sarcopenia
Critical Public Health
TyG-BMI is linked with a higher risk of cardiometabolic multimorbidity in humans (comparing highest vs. lowest quartile) (HR = 2.146).
“closely followed by TyG-BMI (HR = 2.146)”
Humanscomparing highest vs. lowest quartile4.3 yearsn = 304,586
Nutrients
TyG-BMI is linked with a higher risk of cardiometabolic multimorbidity in humans (high index with low eGDR versus low index with high eGDR) (HR 3.40, 95% CI 2.30-5.02).
“TyG-BMI (HR 3.40, 95% CI 2.30-5.02)”
Humanshigh index with low eGDR versus low index with high eGDR
Cardiovascular diabetology
Osteoporosis
downin humans2upin humans1OR 0.985
3 studies
Osteoporosis
downin humans2upin humans1OR 0.985
TyG-BMI is linked with a lower risk of osteoporosis in patients with type 2 diabetes mellitus (OR 0.985, 95% CI 0.978-0.992).
“each one-unit increase in TyG-BMI was associated with a 1.5% lower odds of osteoporosis (OR = 0.985, 95% CI: 0.978-0.992)”
Humansin patients with type 2 diabetes mellitusn = 892
Diabetes, metabolic syndrome and obesity : targets and therapy
TyG-BMI is linked with a lower risk of osteoporosis in humans (adjusted Cox regression) (HR 0.991, 95% CI 0.984-0.999).
“0.991 (95%CI 0.984-0.999) and 0.929 (95%CI 0.892-0.968), respectively”
Humansadjusted Cox regression2015 until 2022malesn = 1,622
Role of TyG, TyG-BMI and METS-IR in osteoporosis risk among older men: a retrospective cohort study
Asia Pacific journal of clinical nutrition
TyG-BMI predicts osteoporosis in patients with T2DM.
“Machine learning analysis identified TyG-BMI as the strongest predictor for type 2 diabetic osteoporosis in middle-aged and elderly patients.”
Humansin patients with T2DM
Frontiers in nutrition
TyG-BMI is linked with a higher risk of osteoporosis in patients with T2DM (95%CI 1.031-1.054, P < 0.01).
“Notably, TyG-BMI also emerged as an independent risk factor for OP (95%CI 1.031-1.054, P < 0.01).”
Humansin patients with T2DM
Frontiers in nutrition
Stroke
upin humans3OR 1.186–1.62
3 studies
Stroke
upin humans3OR 1.186–1.62
TyG-BMI is linked with a higher risk of stroke in humans (abnormal glucose metabolism) (adjusted OR 1.186, 95% CI 1.022-1.376 per SD increase).
“1.186 (1.022-1.376), 1.222 (1.069-1.396), and 1.193 (1.050-1.355), respectively.”
Humansabnormal glucose metabolism
Cardiovascular diabetology
TyG-BMI is linked with a higher risk of stroke in humans (non-hypertension) (HR 1.47 (1.05-2.05)).
“Compared to patients with lower TyG-BMI (TyG-BMI < 199.74) levels and non-hypertension, those with elevated TyG-BMI levels and non-hypertension had an adjusted hazard ratio (HR) and 95% confidence intervals (95%CI) were 1.47 (1.05-2.05).”
Humansnon-hypertension7-year follow-upn = 6,922
Frontiers in public health
TyG-BMI is linked with a higher risk of stroke in humans (middle-aged and older Chinese adults) (OR 1.62, 95% CI 1.11-2.32).
“the OR for a high TyG-BMI with a slow rising trend was 1.62 (95% CI 1.11-2.32)”
Humansmiddle-aged and older Chinese adults3 yearsn = 4,583
Cardiovascular diabetology
Metabolic dysfunction-associated steatotic liver disease
upin humans2
2 studies
Metabolic dysfunction-associated steatotic liver disease
upin humans2
TyG-BMI predicts metabolic dysfunction-associated steatotic liver disease in humans (Chinese health checkup cohort).
“TyG‐BMI, TyG‐WC, TyG‐WHtR, and METs‐IR showed superior discriminative ability (AUC: 0.864–0.929) and outperformed TyG and TyG‐WHR.”
HumansChinese health checkup cohortn = 2,623
Frontiers in endocrinology
TyG-BMI predicts metabolic dysfunction-associated steatotic liver disease in humans (AUC 0.758).
“TyG-BMI demonstrated numerically higher AUC values than the HSI (Men: TyG-BMI 0.758 vs. HSI 0.747; Women: TyG-BMI 0.759 vs. HSI 0.756), with overlapping confidence intervals.”
Humansmedian six-year follow-upmalesn = 2,757
Asia Pacific journal of clinical nutrition
TyG-BMI is linked with a higher risk of metabolic dysfunction-associated steatotic liver disease in humans (highest versus lowest quartile) (aHR 6.42 (95% CI: 5.33-7.73)).
“triglyceride glucose-body mass index (TyG-BMI) demon-strated the highest risk, with an adjusted hazard ratio of 6.42 (95% CI: 5.33-7.73) for the highest versus lowest quartile.”
Humanshighest versus lowest quartilemedian six-year follow-upn = 2,757
Asia Pacific journal of clinical nutrition
More on Metabolic dysfunction-associated steatotic liver disease
Diabetes mellitus
upin humans2OR 1.14
2 studies
Diabetes mellitus
upin humans2OR 1.14
TyG-BMI is linked with a higher risk of diabetes mellitus in humans (liver disease) (OR = 1.14, 95%CI = 1.06-1.22).
“the triglyceride-glucose-body mass index (TyG-BMI) (OR = 1.14, 95%CI = 1.06-1.22) promoted DM in male patients”
Humansliver diseasemales
Diabetology international
TyG-BMI predicts diabetes mellitus in humans (cutoff 213.2966) (AUC 0.7741, sensitivity 72.51%, specificity 69.54%).
“the best TyG-BMI cutoff value for predicting new-onset diabetes was 213.2966 (area under the curve 0.7741, sensitivity 72.51%, specificity 69.54%)”
Humanscutoff 213.29663.1 yearsn = 116,661
Research SquarePreprint
TyG-BMI is linked with a higher risk of diabetes mellitus in humans (multivariate Cox regression) (HR 1.50 per SD increase, 95%CI: 1.40 to 1.60).
“TyG-BMI was an independent predictor of new-onset diabetes (HR 1.50 per SD increase, 95%CI: 1.40 to 1.60, P-trend<0.00001)”
Humansmultivariate Cox regression3.1 yearsn = 116,661
Research SquarePreprint
Frailty
upin humans2OR 1.83–2.16
2 studies
Frailty
upin humans2OR 1.83–2.16
TyG-BMI is associated with frailty in humans (fourth quartile vs first quartile of baseline TyG-BMI) (OR 1.83, 95% CI 1.61-2.09).
“fourth (OR = 1.83, 95% CI: 1.61-2.09) quartiles of baseline TyG-BMI”
Humansfourth quartile vs first quartile of baseline TyG-BMIn = 9,135
Cardiovascular diabetology
TyG-BMI is linked with a higher risk of frailty in humans (fourth quartile vs first quartile of baseline TyG-BMI) (HR 1.42, 95% CI 1.28-1.58).
“Higher frail risk was noted in those in the fourth quartile of baseline TyG-BMI (HR = 1.42, 95% CI: 1.28-1.58)”
Humansfourth quartile vs first quartile of baseline TyG-BMIn = 9,135
Cardiovascular diabetology
TyG-BMI is linked with a higher risk of frailty in humans (fully adjusted model, Q4 vs. Q1) (OR 2.16, 95% CI 1.76–2.64).
“TyG- BMI Q4 vs. Q1, OR = 2.16, 95% CI: 1.76, 2.64, P < 0.001”
Humansfully adjusted model, Q4 vs. Q1n = 7,965
Association of the triglyceride-glucose index and its related parameters with frailty
Lipids in health and disease
Venous thromboembolism
upin humans2HR 1.7–1.86
2 studies
Venous thromboembolism
upin humans2HR 1.7–1.86
TyG-BMI is associated with venous thromboembolism in humans (Highest quartile of TyG-BMI) (HR 1.86, 95% CI 1.76–1.98).
“Participants in the highest quartiles of TyG, TyG-BMI, TyG-WC, TyG-WHtR, TyG-BRI, TyG-ABSI, TyG-WWI, and TyG-VAI exhibited elevated risk of VTE”
HumansHighest quartile of TyG-BMI
Thrombosis and haemostasis
TyG-BMI is linked with a higher risk of venous thromboembolism in humans after adjusting for potential confounders (HR 1.70, 95% CI 1.63–1.76).
“as well as with every 100 unit increase in TyG-BMI (HR: 1.70, 95% CI: 1.63–1.76, P < 0.001, E value = 2.79)”
Humansafter adjusting for potential confoundersevery 100 unit increasen = 502,131
BMC cardiovascular disorders
All 56Fewer
How this record changed
Summary rewritten as its findings changed.
As it read before
One human study links higher TyG-BMI to type 2 diabetes; another links it to hypertension–diabetes comorbidity. A human study reports insulin resistance prediction in adults without diabetes, but another reports no effect on hypertension in people with type 2 diabetes or prediabetes.
Summary written from the findings.